Article

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials-05-01-2020
Volume29
Issue 5

Applied Clinical Trials, May 2020 Issue (PDF)

Click the title above to open the Applied Clinical Trials May 2020 issue in an interactive PDF format.

External Link - ACT May 2020.pdf

Download Issue PDF
Articles in this issue
Closing Thought PQ.png
Pandemic Highlights Urgency for New Methodologies for Evidence Generation
Bridging the Gaps in CAPA Planning in Clinical Trials
Bridging the Gaps in CAPA Planning in Clinical Trials
Central RBM Supports Reduced Cost, Higher Data Quality
Central RBM Supports Reduced Cost, Higher Data Quality
Quality Amid the Chaos: Breaking Down Barriers to New Data Capture Models
Quality Amid the Chaos: Breaking Down Barriers to New Data Capture Models
DMC PQ.png
DMCs: Maintaining Data Integrity in COVID-19 Climate
Jill Wechsler color 132.jpg
More Coordination Sought for Exploding COVID-19 R&D Efforts

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Addressing the Digital Divide in Decentralized Trials
Addressing the Digital Divide in Decentralized Trials
Why Decentralized Trials Face Slow Adoption Despite Strong Data
Why Decentralized Trials Face Slow Adoption Despite Strong Data
How Research Sites Balance Funding Cuts and Efficiency Pressures
How Research Sites Balance Funding Cuts and Efficiency Pressures
Related Content
Credit: Proxima Studio | stock.adobe.com. While BGM remains the regulatory gold standard, CGM is gaining ground in exploratory endpoints and safety monitoring
September 2nd 2025

Beyond the Fingerstick: Navigating CGM and BGM Decisions in GLP-1 Clinical Trials

Karl McEvoy, PhD, and Aubrey Verna
ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains
September 2nd 2025

ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains

Andy Studna, Senior Editor
Image Credit: Adobe Stock Images/Robin
September 2nd 2025

Phase III NIMBLE Trial Demonstrates Cemdisiran Efficacy in Generalized Myasthenia Gravis

Andy Studna, Senior Editor
ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials
September 2nd 2025

ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials

Andy Studna, Senior Editor
Credit: Dzmitry | stock.adobe.com. SMA can range from severe cases that develop during infancy to milder forms of the disease that manifest later in life.
September 2nd 2025

Evrysdi Helps Presymptomatic Infants with Spinal Muscular Atrophy Sit, Stand, and Walk in Phase II Trial

Davy James
Phase I/II RAINFOL-01 Trial Results Lead to FDA Breakthrough Designation for Genmab’s Rina-S for Advanced Endometrial Cancer
September 2nd 2025

Phase I/II RAINFOL-01 Trial Results Lead to FDA Breakthrough Designation for Genmab’s Rina-S for Advanced Endometrial Cancer

Don Tracy, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.